Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
Active, not recruiting · NCT06667037 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control | eye disorder, myopia, refractive error | Active, not recruiting | Not applicable | 2026-08-18 | NCT06667037 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Ophthalmic Center Sun Yat-Sen University | Guangzhou | China | 2 |